Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-889-AG25 | 19-11-2025 | Scienza Chile SpA | Recepcion Conforme | $5.414.500 |
| 2980-895-AG25 | 19-11-2025 | Gador Limitada | Recepcion Conforme | $4.209.749 |
| 2980-897-AG25 | 19-11-2025 | Synthon Chile Limitada | Recepcion Conforme | $1.216.180 |
| 2980-898-AG25 | 19-11-2025 | Pharmaxpress SpA | Recepcion Conforme | $1.414.910 |
| 2980-899-AG25 | 19-11-2025 | Novartis Chile S.A. | Recepcion Conforme | $4.797.323 |
| 2980-900-AG25 | 19-11-2025 | Gador Limitada | Recepcion Conforme | $4.373.250 |
| 2980-903-AG25 | 19-11-2025 | Pfizer Chile S.A. | Recepcion Conforme | $3.519.235 |
| 2980-912-AG25 | 19-11-2025 | Astrazeneca S.A. | Recepcion Conforme | $4.955.084 |
| 2980-407-AG25 | 13-11-2025 | Global Ventas y Servicios SpA | Recepcion Conforme | $701.962 |
| 2980-413-AG25 | 13-11-2025 | Inversiones Sb S.A. | Recepcion Conforme | $481.950 |
| 2980-416-AG25 | 13-11-2025 | Novartis Chile S.A. | Recepcion Conforme | $5.895.474 |
| 2980-405-AG25 | 11-11-2025 | Laboratorios Elea Chile SpA | Recepcion Conforme | $2.088.450 |
| 2980-408-AG25 | 11-11-2025 | Novartis Chile S.A. | Recepcion Conforme | $2.927.257 |
| 2980-409-AG25 | 11-11-2025 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $544.217 |
| 2980-410-AG25 | 11-11-2025 | Gador Limitada | Recepcion Conforme | $4.209.749 |
| 2980-362-AG25 | 05-11-2025 | Emcure Pharma Chile SpA | Aceptada | $202.419 |
| 2980-404-AG25 | 29-10-2025 | Seven Pharma Chile SpA | Recepcion Conforme | $601.802 |
| 2980-402-AG25 | 28-10-2025 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $6.669.902 |
| 2980-403-AG25 | 28-10-2025 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-389-AG25 | 22-10-2025 | Synthon Chile Limitada | Recepcion Conforme | $729.708 |
| 2980-365-AG25 | 21-10-2025 | Novartis Chile S.A. | Recepcion Conforme | $4.285.428 |
| 2980-379-AG25 | 21-10-2025 | Gador Limitada | Recepcion Conforme | $3.355.800 |
| 2980-381-AG25 | 21-10-2025 | Novartis Chile S.A. | Recepcion Conforme | $5.539.500 |
| 2980-382-AG25 | 21-10-2025 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $4.748.100 |
| 2980-384-AG25 | 21-10-2025 | Novartis Chile S.A. | Recepcion Conforme | $5.895.474 |
| 2980-390-AG25 | 21-10-2025 | Comercializadora de Alimentos Especializados, Medicamentos y Dispositivos Medico | Recepcion Conforme | $542.640 |
| 2980-391-AG25 | 21-10-2025 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $3.094.000 |
| 2980-392-SE25 | 21-10-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $17.950.829 |
| 2980-393-SE25 | 21-10-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $1.812.367 |
| 2980-394-SE25 | 21-10-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $2.339.425 |
